Ann M Veneman has sold ALXN and made no open-market buys since Aug 2017

Director at Alexion Pharmaceuticals, Inc.

SEC CIK 0001493023 · Filings on SEC.gov ↗

Filings come from SEC EDGAR. Not investment advice.